mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0096 |
0.8 |
mRNA |
cimetidine |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.8 |
mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0093 |
0.8 |
mRNA |
Z-LLNle-CHO |
GDSC1000 |
pan-cancer |
AAC |
-0.014 |
0.8 |
mRNA |
paclitaxel |
UHNBreast |
pan-cancer |
AAC |
0.095 |
0.8 |
mRNA |
lomeguatrib |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
B02 |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
Vorinostat |
CTRPv2 |
pan-cancer |
AAC |
-0.0092 |
0.8 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.0079 |
0.8 |